Figure 2From: Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report Evolution of visual field testing (24-2) over the course of docetaxel toxic optic neuropathy (Total Deviation and Grayscale). A- On Presentation, B- 5 days after presentation, C- 3 weeks after presentation, D- 5 weeks after presentation, E- 13 weeks after presentation.Back to article page